Inspire Medical Systems, Inc. (INSP) stock
INSPNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 19/3057% below fair value
$59.41+0.29 (+0.49%)
Close on Nov 17, 2026Market cap $1.72BP/E 12.9Yield –
Inspire Medical Systems total assets
Total assets on the balance sheet at the end of each period.
Inspire Medical Systems's total assets was $925.99M at Jun 30, 2026. For fiscal 2025 it was $907.32M, up 12.2% from the year before. The highest annual figure on record is $907.32M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $907.32M | +12.2% |
| FY2024 | Dec 31, 2024 | $808.38M | +19.4% |
| FY2023 | Dec 31, 2023 | $676.81M | +19.8% |
| FY2022 | Dec 31, 2022 | $564.88M | +91.4% |
| FY2021 | Dec 31, 2021 | $295.08M | +4.9% |
| FY2020 | Dec 31, 2020 | $281.19M | +55.1% |
| FY2019 | Dec 31, 2019 | $181.25M | -9.4% |
| FY2018 | Dec 31, 2018 | $200.08M | +697.4% |
| FY2017 | Dec 31, 2017 | $25.09M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $925.99M | +15.4% |
| Q1 FY2026 | Mar 31, 2026 | $911.38M | +24.7% |
| Q4 FY2025 | Dec 31, 2025 | $907.32M | +12.2% |
| Q3 FY2025 | Sep 30, 2025 | $807.72M | +1.4% |
| Q2 FY2025 | Jun 30, 2025 | $802.19M | +10.1% |
| Q1 FY2025 | Mar 31, 2025 | $730.81M | +6.6% |
| Q4 FY2024 | Dec 31, 2024 | $808.38M | +19.4% |
| Q3 FY2024 | Sep 30, 2024 | $796.19M | +24.5% |
| Q2 FY2024 | Jun 30, 2024 | $728.39M | +17.8% |
| Q1 FY2024 | Mar 31, 2024 | $685.84M | +19.9% |
| Q4 FY2023 | Dec 31, 2023 | $676.81M | +19.8% |
| Q3 FY2023 | Sep 30, 2023 | $639.49M | +21.2% |
| Q2 FY2023 | Jun 30, 2023 | $618.25M | +111.7% |
| Q1 FY2023 | Mar 31, 2023 | $571.85M | +97.4% |
| Q4 FY2022 | Dec 31, 2022 | $564.88M | +91.4% |
| Q3 FY2022 | Sep 30, 2022 | $527.52M | +89.1% |
| Q2 FY2022 | Jun 30, 2022 | $292.00M | +7.3% |
| Q1 FY2022 | Mar 31, 2022 | $289.72M | +6.0% |
| Q4 FY2021 | Dec 31, 2021 | $295.08M | +4.9% |
| Q3 FY2021 | Sep 30, 2021 | $278.89M | +2.6% |
| Q2 FY2021 | Jun 30, 2021 | $272.21M | +0.3% |
| Q1 FY2021 | Mar 31, 2021 | $273.41M | +65.0% |
| Q4 FY2020 | Dec 31, 2020 | $281.19M | +55.1% |
| Q3 FY2020 | Sep 30, 2020 | $271.78M | +48.3% |
| Q2 FY2020 | Jun 30, 2020 | $271.31M | +46.2% |
| Q1 FY2020 | Mar 31, 2020 | $165.74M | -12.6% |
| Q4 FY2019 | Dec 31, 2019 | $181.25M | -9.4% |
| Q3 FY2019 | Sep 30, 2019 | $183.23M | +40.2% |
| Q2 FY2019 | Jun 30, 2019 | $185.57M | +38.6% |
| Q1 FY2019 | Mar 31, 2019 | $189.61M | +580.7% |
| Q4 FY2018 | Dec 31, 2018 | $200.08M | +697.4% |
| Q3 FY2018 | Sep 30, 2018 | $130.72M | – |
| Q2 FY2018 | Jun 30, 2018 | $133.89M | – |
| Q1 FY2018 | Mar 31, 2018 | $27.85M | – |
| Q4 FY2017 | Dec 31, 2017 | $25.09M | – |
See a number that looks wrong?